{
  "meta": {
    "title": "17_Cholinergic_Drugs",
    "url": "https://brainandscalpel.vercel.app/17-cholinergic-drugs-da7403fd.html",
    "scrapedAt": "2025-11-30T06:59:44.447Z"
  },
  "questions": [
    {
      "id": 61193,
      "choices": [
        {
          "id": 289983,
          "text": "Edrophonium"
        },
        {
          "id": 289984,
          "text": "Pralidoxime"
        },
        {
          "id": 289985,
          "text": "Tacrine"
        },
        {
          "id": 289986,
          "text": "Parathion"
        }
      ],
      "text": "Anionic site of acetylcholine esterase enzyme can be occupied by all except",
      "unique_key": "Q4199395",
      "question_audio": null,
      "question_video": null,
      "map_id": 34759685,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Parathion because parathion is an organophosphate insecticide that inhibits acetylcholinesterase (AChE) by phosphorylating its serine hydroxyl group at the esteratic site, not by binding to the anionic site. Organophosphates act as irreversible inhibitors of AChE, leading to accumulation of acetylcholine at synapses, which results in cholinergic toxicity. The anionic site of AChE is responsible for binding the quaternary ammonium group of acetylcholine, but parathion does not interact with this site. Instead, it undergoes metabolic activation in the liver to paraoxon, which then covalently modifies the enzyme at the esteratic site, leading to enzyme inhibition. Explanation of Incorrect Options: A. Edrophonium – Edrophonium is a reversible acetylcholinesterase inhibitor that binds specifically to the anionic site of the enzyme. It contains a quaternary ammonium group, which allows it to interact with the anionic site, leading to a transient inhibition of AChE. This property makes it useful in diagnosing myasthenia gravis (Tensilon test). B. Pralidoxime – Pralidoxime (2-PAM) is an oxime that can reactivate AChE inhibited by organophosphates. It binds to the anionic site of AChE and removes the phosphoryl group from the enzyme's esteratic site, thereby restoring enzyme function. While pralidoxime primarily acts on the esteratic site, its structure allows it to transiently associate with the anionic site as well. C. Tacrine – Tacrine is a reversible AChE inhibitor used in the treatment of Alzheimer’s disease. It binds to both the anionic site and the esteratic site of AChE, preventing acetylcholine breakdown and increasing its levels in the synaptic cleft.",
      "correct_choice_id": 289986,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51461441700117308/51461441700117308.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/51461441700117308/51461441700117308.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61194,
      "choices": [
        {
          "id": 289987,
          "text": "Anionic site of acetylcholine esterase enzyme"
        },
        {
          "id": 289988,
          "text": "Esteratic site of acetylcholine esterase enzyme"
        },
        {
          "id": 289989,
          "text": "Both A and B"
        },
        {
          "id": 289990,
          "text": "None of the above"
        }
      ],
      "text": "Edrophonium binds to",
      "unique_key": "Q7792483",
      "question_audio": null,
      "question_video": null,
      "map_id": 34754207,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Anionic site of acetylcholinesterase enzyme because edrophonium is a reversible acetylcholinesterase (AChE) inhibitor that primarily binds to the anionic site of the enzyme. The anionic site is responsible for attracting and positioning acetylcholine via its quaternary ammonium group. Since edrophonium also possesses a quaternary ammonium group, it interacts with the anionic site through electrostatic interactions, leading to transient inhibition of AChE. This brief inhibition increases acetylcholine levels at the neuromuscular junction, which is why edrophonium is used in the Tensilon test for diagnosing myasthenia gravis. Its action is short-lived due to its rapid reversible binding. Explanation of Incorrect Options: B. Esteratic site of acetylcholinesterase enzyme – The esteratic site of AChE contains a serine hydroxyl group, which plays a crucial role in the hydrolysis of acetylcholine. Unlike carbamates (e.g., neostigmine, physostigmine) or organophosphates (e.g., parathion), edrophonium does not form covalent bonds with the esteratic site. Instead, it acts purely via reversible electrostatic interaction at the anionic site, making this option incorrect. C. Both A and B – Since edrophonium binds only to the anionic site and does not interact with the esteratic site, this option is incorrect. D. None of the above – Edrophonium does bind to the anionic site of AChE, making this option incorrect.",
      "correct_choice_id": 289987,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34179701700117387/34179701700117387.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34179701700117387/34179701700117387.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61195,
      "choices": [
        {
          "id": 289991,
          "text": "Formation of acetate inside Presynaptic membrane"
        },
        {
          "id": 289992,
          "text": "Synthesis of acetyl cholinesterase enzyme"
        },
        {
          "id": 289993,
          "text": "Acetyl CoA synthesis"
        },
        {
          "id": 289994,
          "text": "Choline uptake inside Presynaptic membrane"
        }
      ],
      "text": "Rate limiting step in ACh synthesis is",
      "unique_key": "Q1946176",
      "question_audio": null,
      "question_video": null,
      "map_id": 34190961,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Choline uptake inside presynaptic membrane because the rate-limiting step in acetylcholine (ACh) synthesis is the active transport of choline into the presynaptic neuron. Choline is taken up from the extracellular space by a high-affinity choline transporter (ChT-1) present on the presynaptic membrane. This process is sodium-dependent and crucial because neurons rely on extracellular choline for ACh production. Once inside the neuron, choline is acetylated by the enzyme choline acetyltransferase (ChAT) using acetyl-CoA, forming acetylcholine. Since the availability of free choline directly affects ACh synthesis, its uptake is the rate-limiting step. Explanation of Incorrect Options: A. Formation of acetate inside presynaptic membrane – Acetate is not directly involved in ACh synthesis. Instead, acetyl-CoA, derived from mitochondrial metabolism, provides the acetyl group for acetylcholine synthesis. Acetate formation does not regulate the rate of ACh production, making this option incorrect. B. Synthesis of acetylcholinesterase enzyme – Acetylcholinesterase (AChE) is responsible for breaking down acetylcholine in the synaptic cleft but does not participate in its synthesis. The regulation of ACh synthesis depends on choline availability, not AChE levels, so this option is incorrect. C. Acetyl-CoA synthesis – Although acetyl-CoA is essential for ACh synthesis, it is readily available in neurons through metabolic pathways like glycolysis and the Krebs cycle. Since its production does not limit the rate of ACh formation, this option is incorrect.",
      "correct_choice_id": 289994,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46920821700117457/46920821700117457.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/46920821700117457/46920821700117457.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61196,
      "choices": [
        {
          "id": 289995,
          "text": "X"
        },
        {
          "id": 289996,
          "text": "IX"
        },
        {
          "id": 289997,
          "text": "III"
        },
        {
          "id": 289998,
          "text": "VI"
        }
      ],
      "text": "Which of the following cranial nerves doesn’t have parasympathetic nerves",
      "unique_key": "Q3992930",
      "question_audio": null,
      "question_video": null,
      "map_id": 34413718,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) VI (Abducens nerve) because the abducens nerve (cranial nerve VI) is a purely motor nerve responsible for the lateral movement of the eyeball by innervating the lateral rectus muscle. It does not contain any parasympathetic fibers or contribute to autonomic functions like glandular secretion or smooth muscle control. Instead, its function is limited to somatic motor control, making it the correct answer. Explanation of Incorrect Options: A. X (Vagus nerve) – The vagus nerve (cranial nerve X) carries extensive parasympathetic fibers that regulate autonomic functions in the heart, lungs, and digestive tract. It is the primary parasympathetic nerve in the body, controlling functions like heart rate slowing, bronchoconstriction, and gastrointestinal motility. Since it has strong parasympathetic components, this option is incorrect. B. IX (Glossopharyngeal nerve) – The glossopharyngeal nerve (cranial nerve IX) has parasympathetic fibers that innervate the parotid salivary gland through the otic ganglion. It is involved in autonomic control of saliva secretion, making this option incorrect. C. III (Oculomotor nerve) – The oculomotor nerve (cranial nerve III) carries parasympathetic fibers to the pupillary sphincter and ciliary muscles, which control pupil constriction (miosis) and lens accommodation. The parasympathetic fibers originate in the Edinger-Westphal nucleus and synapse in the ciliary ganglion. Since it has a parasympathetic function, this option is incorrect.",
      "correct_choice_id": 289998,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/15781700117506/15781700117506.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/15781700117506/15781700117506.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61197,
      "choices": [
        {
          "id": 289999,
          "text": "The Esteric site of the enzyme is not free to provide attachment"
        },
        {
          "id": 290000,
          "text": "Has weak anti-ChE activity"
        },
        {
          "id": 290001,
          "text": "The anionic site of the enzyme is not free to provide attachment"
        },
        {
          "id": 290002,
          "text": "Both A and C"
        }
      ],
      "text": "Pralidoxime is ineffective as an antidote to carbaryl due to",
      "unique_key": "Q9023772",
      "question_audio": null,
      "question_video": null,
      "map_id": 34494953,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) The anionic site of the enzyme is not free to provide attachment because pralidoxime (2-PAM) works by reactivating acetylcholinesterase (AChE) that has been inhibited by organophosphates. It does this by binding to the anionic site of the enzyme and then removing the phosphoryl group from the esteratic site. However, in the case of carbamate poisoning (e.g., carbaryl), the inhibition of AChE is reversible and short-lived, and the anionic site remains occupied by the carbamate molecule. Since pralidoxime requires the anionic site for binding, it cannot effectively displace the carbamate inhibitor, making it ineffective as an antidote for carbaryl poisoning. Explanation of Incorrect Options: A. The Esteratic site of the enzyme is not free to provide attachment – While carbamates do bind to the esteratic site of AChE, their inhibition is spontaneously reversible, meaning the enzyme recovers on its own over time. Unlike organophosphates, which form a strong covalent bond with the esteratic site, carbamates do not cause permanent inhibition, and pralidoxime does not need to act on the esteratic site. Therefore, this is not the correct reason for pralidoxime’s ineffectiveness. B. Has weak anti-ChE activity – Pralidoxime itself does not directly inhibit AChE; instead, it reactivates the enzyme by removing organophosphate inhibition. Its effectiveness is dependent on whether the enzyme is phosphorylated, not on any intrinsic ability to inhibit AChE. This option is incorrect. D. Both A and C – While the esteratic site is occupied temporarily by carbamates, pralidoxime’s primary issue is its inability to attach to the anionic site. Since option A is not entirely correct, this combined option is also incorrect.",
      "correct_choice_id": 290001,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26267431700117638/26267431700117638.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/26267431700117638/26267431700117638.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61198,
      "choices": [
        {
          "id": 290003,
          "text": "Glaucoma"
        },
        {
          "id": 290004,
          "text": "Post-operative shivering"
        },
        {
          "id": 290005,
          "text": "Myasthenia gravis"
        },
        {
          "id": 290006,
          "text": "Post-operative atony"
        }
      ],
      "text": "Which of the following is not a use of Cholinomimetic Drugs",
      "unique_key": "Q3618383",
      "question_audio": null,
      "question_video": null,
      "map_id": 34873974,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Post-operative shivering because cholinomimetic drugs (which mimic the action of acetylcholine) do not play a role in treating post-operative shivering. Post-operative shivering is usually managed with drugs like meperidine (an opioid), clonidine (an α2-agonist), or dexmedetomidine, which modulate thermoregulation through different mechanisms. Cholinergic stimulation does not significantly affect the thermoregulatory pathways involved in shivering, making cholinomimetics ineffective for this condition. Explanation of Incorrect Options: A. Glaucoma – Cholinomimetic drugs, such as pilocarpine and carbachol, are used in glaucoma because they cause miosis (pupil constriction) and increase the outflow of aqueous humor through the trabecular meshwork. This helps lower intraocular pressure, making cholinomimetics useful in open-angle and acute angle-closure glaucoma. C. Myasthenia gravis – Cholinomimetic drugs, particularly indirect-acting acetylcholinesterase inhibitors like neostigmine, pyridostigmine, and edrophonium, are used to increase acetylcholine levels at the neuromuscular junction, thereby improving muscle strength in myasthenia gravis. This is a key therapeutic use of cholinomimetics. D. Post-operative atony – Bethanechol and neostigmine, both cholinomimetic drugs, are used to stimulate smooth muscle contractions in cases of post-operative bladder atony and paralytic ileus. They help restore normal motility in the gastrointestinal and urinary tracts by enhancing cholinergic stimulation.",
      "correct_choice_id": 290004,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59962671700118263/59962671700118263.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59962671700118263/59962671700118263.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61199,
      "choices": [
        {
          "id": 290007,
          "text": "Muscarine"
        },
        {
          "id": 290008,
          "text": "Methacholine"
        },
        {
          "id": 290009,
          "text": "Pilocarpine"
        },
        {
          "id": 290010,
          "text": "Arecholine"
        }
      ],
      "text": "Following directly acting cholinergic drugs are natural alkaloids except",
      "unique_key": "Q9158466",
      "question_audio": null,
      "question_video": null,
      "map_id": 34207475,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Methacholine because methacholine is a synthetic choline ester, not a natural alkaloid. It is a direct-acting cholinergic agonist that primarily stimulates muscarinic receptors. Methacholine is structurally related to acetylcholine but has a methyl group that makes it more resistant to degradation by acetylcholinesterase. It is commonly used in the methacholine challenge test to diagnose bronchial hyperreactivity in asthma. Unlike the other options, methacholine is not derived from natural plant sources, making it the correct answer. Explanation of Incorrect Options: A. Muscarine – Muscarine is a natural alkaloid found in certain mushrooms, particularly Amanita muscaria. It is a direct muscarinic receptor agonist with no effect on nicotinic receptors. It mimics acetylcholine at parasympathetic sites, leading to symptoms like salivation, lacrimation, bradycardia, and bronchoconstriction when ingested. Since it is a natural compound, this option is incorrect. C. Pilocarpine – Pilocarpine is a naturally occurring alkaloid derived from the Pilocarpus plant species. It is a muscarinic receptor agonist used to treat glaucoma (by increasing aqueous humor outflow) and xerostomia (dry mouth, as seen in Sjögren’s syndrome). Since it is a natural alkaloid, this option is incorrect. D. Arecoline – Arecoline is a natural alkaloid found in the betel nut (Areca catechu). It acts as a muscarinic and nicotinic receptor agonist, stimulating the autonomic nervous system. Arecoline is responsible for the mild stimulant effects of betel nut chewing, which is common in certain cultures. Since it is a natural compound, this option is incorrect.",
      "correct_choice_id": 290008,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57631231700118284/57631231700118284.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/57631231700118284/57631231700118284.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61200,
      "choices": [
        {
          "id": 290011,
          "text": "Increased cognitive function"
        },
        {
          "id": 290012,
          "text": "Increased seizure activity"
        },
        {
          "id": 290013,
          "text": "Increase in dopamine release and locomotion"
        },
        {
          "id": 290014,
          "text": "Increase in depolarization of autonomic ganglia"
        }
      ],
      "text": "Stimulation of M1 receptor leads to following action except",
      "unique_key": "Q4363808",
      "question_audio": null,
      "question_video": null,
      "map_id": 34923162,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Muscarinic M1 receptors are Gq-protein coupled receptors that are primarily found in the central nervous system (CNS), autonomic ganglia, and gastric parietal cells. They play a key role in cognitive functions and neuronal excitability. However, M1 receptor stimulation does not increase dopamine release or locomotion—in fact, it often has the opposite effect by modulating dopamine pathways in the brain, particularly in the striatum and basal ganglia. Increased dopamine release is more commonly associated with M4 inhibition rather than M1 stimulation. Incorrect Options: A. Increased cognitive function – M1 receptors are heavily involved in memory and learning, especially in the hippocampus and cortex. Stimulation of M1 receptors enhances cognitive processes, and their dysfunction has been linked to diseases like Alzheimer’s disease. B. Increased seizure activity – Overactivation of M1 receptors can lead to neuronal hyperexcitability, which can contribute to seizures. This is seen in conditions such as cholinergic toxicity or epileptic disorders where excessive cholinergic activity triggers seizure episodes. D. Increase in depolarization of autonomic ganglia – M1 receptors are present in autonomic ganglia and facilitate synaptic transmission by increasing depolarization. They enhance neuronal excitability in the sympathetic and parasympathetic ganglia, leading to more efficient neurotransmission.",
      "correct_choice_id": 290013,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2866331700118300/2866331700118300.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2866331700118300/2866331700118300.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61201,
      "choices": [
        {
          "id": 290015,
          "text": "Acetylcholine esterase"
        },
        {
          "id": 290016,
          "text": "Angiotensin converting enzyme"
        },
        {
          "id": 290017,
          "text": "Butyryl cholinesterase"
        },
        {
          "id": 290018,
          "text": "All of the above"
        }
      ],
      "text": "Which of the following enzyme is more sensitive to organophosphates",
      "unique_key": "Q4547681",
      "question_audio": null,
      "question_video": null,
      "map_id": 34819967,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Butyryl cholinesterase Butyryl cholinesterase, also known as pseudocholinesterase, is more sensitive to inhibition by organophosphates than acetylcholine esterase. It is found mainly in plasma and is commonly used as an early biomarker for organophosphate exposure. Since it reacts with even small amounts of organophosphate compounds, its activity drops before clinical symptoms appear, making it valuable for early detection in subclinical or chronic exposures. Although it is not directly responsible for clinical symptoms (which are due to acetylcholine esterase inhibition), its higher sensitivity makes it a preferred enzyme for monitoring exposure. Incorrect Answers: A. Acetylcholine esterase Incorrect – This is the primary enzyme whose inhibition leads to clinical signs and symptoms in organophosphate poisoning, such as muscle fasciculations and respiratory failure. However, it is less sensitive than butyryl cholinesterase and is not as useful for early detection. B. Angiotensin converting enzyme (ACE) Incorrect – ACE is involved in the renin-angiotensin system and has no role in cholinergic transmission. It is not affected by organophosphates. D. All of the above Incorrect – Since ACE is not inhibited by organophosphates, this option is incorrect.",
      "correct_choice_id": 290017,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2866991700118328/2866991700118328.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2866991700118328/2866991700118328.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61202,
      "choices": [
        {
          "id": 290019,
          "text": "Dopamine"
        },
        {
          "id": 290020,
          "text": "Adrenaline"
        },
        {
          "id": 290021,
          "text": "Noradrenaline"
        },
        {
          "id": 290022,
          "text": "Acetylcholine"
        }
      ],
      "text": "The neurotransmitter agent that is normally released in the SA node of the heart in response to increased blood pressure is",
      "unique_key": "Q3013108",
      "question_audio": null,
      "question_video": null,
      "map_id": 34788335,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Whenever blood pressure increases there is reflex stimulation of baroreceptors. baroreceptors in turn stimulate vagus. vagus release ACh and depresses the heart.",
      "correct_choice_id": 290022,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40251571700119632/40251571700119632.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/40251571700119632/40251571700119632.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61203,
      "choices": [
        {
          "id": 290023,
          "text": "Neostigmine"
        },
        {
          "id": 290024,
          "text": "Pilocarpine"
        },
        {
          "id": 290025,
          "text": "Methacholine"
        },
        {
          "id": 290026,
          "text": "Physostigmine"
        }
      ],
      "text": "You are being asked to give your expert opinion as a toxicologist regarding an effective antidote for belladonna poisoning. Which of the following agents would you suggest?",
      "unique_key": "Q4170728",
      "question_audio": null,
      "question_video": null,
      "map_id": 34271832,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Physostigmine because belladonna poisoning is caused by the anticholinergic effects of alkaloids such as atropine and scopolamine, which block muscarinic receptors, leading to symptoms like dry mouth, tachycardia, mydriasis, urinary retention, hallucinations, and hyperthermia. Physostigmine is a reversible acetylcholinesterase inhibitor that increases acetylcholine levels, thereby overcoming muscarinic blockade and reversing CNS and peripheral symptoms. Unlike other cholinesterase inhibitors, physostigmine is lipid-soluble, allowing it to cross the blood-brain barrier (BBB) and treat both central and peripheral anticholinergic toxicity, making it the most effective antidote for belladonna poisoning. Explanation of Incorrect Options: A. Neostigmine – Although neostigmine is also a cholinesterase inhibitor, it is quaternary in structure, meaning it does not cross the BBB. This makes it ineffective in treating the central effects of belladonna poisoning, such as delirium and hallucinations. Additionally, neostigmine primarily acts at the neuromuscular junction, making it less effective against muscarinic receptor blockade. B. Pilocarpine – Pilocarpine is a direct muscarinic agonist, meaning it can stimulate muscarinic receptors without needing acetylcholine. However, its effects are localized and short-acting, and it does not counteract CNS toxicity. Moreover, pilocarpine is typically used in conditions like glaucoma and xerostomia, rather than systemic anticholinergic poisoning. C. Methacholine – Methacholine is another direct-acting muscarinic agonist, mainly used for bronchial challenge tests in asthma diagnosis. Like pilocarpine, it does not restore acetylcholine levels or reverse CNS symptoms, making it ineffective as an antidote for belladonna poisoning.",
      "correct_choice_id": 290026,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71705921700119755/71705921700119755.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/71705921700119755/71705921700119755.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61204,
      "choices": [
        {
          "id": 290027,
          "text": "Bronchodilation"
        },
        {
          "id": 290028,
          "text": "Cycloplegia"
        },
        {
          "id": 290029,
          "text": "Irreversible inhibition of acetylcholinesterase"
        },
        {
          "id": 290030,
          "text": "Diarrhea"
        }
      ],
      "text": "Mr. James has just been diagnosed with myasthenia gravis. You are his physician and are considering different therapies for his disease. Neostigmine and pyridostigmine may cause which one of the following?",
      "unique_key": "Q7372968",
      "question_audio": null,
      "question_video": null,
      "map_id": 34866917,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Diarrhea because neostigmine and pyridostigmine are reversible acetylcholinesterase inhibitors that increase acetylcholine (ACh) levels at the neuromuscular junction to improve muscle strength in myasthenia gravis. However, they also enhance cholinergic activity at muscarinic receptors in the gastrointestinal (GI) tract, leading to increased peristalsis, intestinal secretions, and diarrhea. This is a common adverse effect of cholinesterase inhibitors due to excessive parasympathetic stimulation. Other cholinergic side effects may include salivation, bradycardia, and excessive sweating. Explanation of Incorrect Options: A. Bronchodilation – Neostigmine and pyridostigmine increase cholinergic activity, which leads to bronchoconstriction, not bronchodilation. Stimulation of muscarinic (M3) receptors in the airways results in increased mucus secretion and airway constriction, which can worsen conditions like asthma or COPD. Thus, this option is incorrect. B. Cycloplegia – Cycloplegia (loss of accommodation) occurs due to muscarinic receptor blockade, as seen with anticholinergic drugs like atropine. Since neostigmine and pyridostigmine increase cholinergic activity rather than blocking it, they can cause miosis (pupil constriction) rather than cycloplegia. Therefore, this option is incorrect. C. Irreversible inhibition of acetylcholinesterase – Neostigmine and pyridostigmine are reversible acetylcholinesterase inhibitors, meaning their effects are temporary. In contrast, organophosphates (e.g., malathion, parathion, sarin gas) cause irreversible inhibition of acetylcholinesterase by phosphorylating the enzyme, leading to prolonged cholinergic toxicity. Since neostigmine and pyridostigmine do not cause irreversible inhibition, this option is incorrect.",
      "correct_choice_id": 290030,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2592771700119869/2592771700119869.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2592771700119869/2592771700119869.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61205,
      "choices": [
        {
          "id": 290031,
          "text": "Organophosphate poisoning"
        },
        {
          "id": 290032,
          "text": "Acetaminophen overdose"
        },
        {
          "id": 290033,
          "text": "Amphetamine toxicity"
        },
        {
          "id": 290034,
          "text": "Atropine poisoning"
        }
      ],
      "text": "Sunder Lal, 28-year-old farmer is found convulsing in the farm. Heart rate is 100/min and blood pressure is 180/110 mm Hg. Diarrhea, sweating and urination are apparent. Pupils are pin point. Drug poisoning is suspected. Most probable cause is",
      "unique_key": "Q6207556",
      "question_audio": null,
      "question_video": null,
      "map_id": 34779098,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) The most probable cause of Sunder Lal’s condition is organophosphate poisoning (Option A). Organophosphates are commonly used as pesticides in farming, and exposure—either through inhalation, ingestion, or skin contact—can lead to cholinergic crisis by inhibiting acetylcholinesterase, an enzyme responsible for breaking down acetylcholine. This results in excessive accumulation of acetylcholine at nerve synapses, leading to muscarinic, nicotinic, and central nervous system (CNS) effects. The patient's pinpoint pupils (miosis), convulsions, diarrhea, sweating, urination, and hypertension are classic signs of cholinergic excess, confirming organophosphate poisoning. Other symptoms may include bronchospasm, salivation, lacrimation, muscle fasciculations, and respiratory distress. The standard treatment includes atropine (a muscarinic antagonist) and pralidoxime (which reactivates acetylcholinesterase if given early). Explanation of Incorrect Options: B. Acetaminophen overdose Acetaminophen (paracetamol) toxicity primarily causes hepatic damage, leading to nausea, vomiting, right upper quadrant pain, jaundice, and potentially liver failure. It does not cause convulsions, pinpoint pupils, or excessive cholinergic symptoms. Hypertension is also not a typical feature. Therefore, this option is incorrect. C. Amphetamine toxicity Amphetamines are stimulants that increase dopamine and norepinephrine levels. This would lead to dilated pupils (mydriasis), agitation, tachycardia, and hyperthermia, rather than pinpoint pupils and cholinergic symptoms. Additionally, amphetamine poisoning usually presents with dry skin rather than excessive sweating, diarrhea, and urination. Hence, it is not the correct answer. D. Atropine poisoning Atropine is an anticholinergic drug that blocks muscarinic receptors, leading to mydriasis (dilated pupils), dry skin, dry mouth, urinary retention, tachycardia, and hyperthermia. The classic mnemonic for atropine toxicity is \"hot as a hare, blind as a bat, dry as a bone, red as a beet, and mad as a hatter\", which contrasts sharply with the cholinergic excess seen in the patient (sweating, diarrhea, urination, and miosis). This makes atropine poisoning an incorrect option.",
      "correct_choice_id": 290031,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49775431700119984/49775431700119984.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/49775431700119984/49775431700119984.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61206,
      "choices": [
        {
          "id": 290035,
          "text": "Pilocarpine"
        },
        {
          "id": 290036,
          "text": "Acetylcholine"
        },
        {
          "id": 290037,
          "text": "Physostigmine"
        },
        {
          "id": 290038,
          "text": "Neostigmine"
        }
      ],
      "text": "A direct acting cholinomimetic that is lipid soluble and has been used in the treatment of glaucoma is",
      "unique_key": "Q7791189",
      "question_audio": null,
      "question_video": null,
      "map_id": 34671340,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Pilocarpine. Pilocarpine is a direct-acting cholinomimetic (muscarinic agonist) that is lipid-soluble, allowing it to penetrate the cornea effectively when used as eye drops. It is primarily used in the treatment of glaucoma, particularly acute angle-closure glaucoma and chronic open-angle glaucoma, because it induces miosis (pupil constriction) by stimulating the muscarinic receptors in the eye. This leads to increased aqueous humor outflow by opening the trabecular meshwork, thereby reducing intraocular pressure (IOP). Pilocarpine is also useful in Sjogren’s syndrome to increase salivation and lacrimation. Explanation of Incorrect Options: B. Acetylcholine Acetylcholine is a direct-acting cholinomimetic, but it is not lipid-soluble and has a very short half-life due to rapid degradation by acetylcholinesterase. This makes it unsuitable for therapeutic use in glaucoma, as it does not provide sustained action. Therefore, this option is incorrect. C. Physostigmine Physostigmine is lipid-soluble, but it is an indirect-acting cholinomimetic (a reversible acetylcholinesterase inhibitor) rather than a direct muscarinic agonist. It can cross the blood-brain barrier (BBB) and is mainly used for the reversal of anticholinergic toxicity (e.g., atropine overdose) rather than glaucoma treatment. While it does have some effect on the eye, pilocarpine is preferred due to its direct action and better therapeutic profile for glaucoma. Hence, this option is incorrect. D. Neostigmine Neostigmine is an indirect-acting cholinomimetic (acetylcholinesterase inhibitor), but unlike physostigmine, it is not lipid-soluble and does not cross the blood-brain barrier. It is mainly used for myasthenia gravis, postoperative urinary retention, and reversal of neuromuscular blockade rather than for glaucoma. Since it lacks lipid solubility, it is not effective for eye-related conditions. Thus, this option is incorrect.",
      "correct_choice_id": 290035,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34480481700120157/34480481700120157.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34480481700120157/34480481700120157.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61207,
      "choices": [
        {
          "id": 290039,
          "text": "Bronchospasm"
        },
        {
          "id": 290040,
          "text": "Diarrhea"
        },
        {
          "id": 290041,
          "text": "Cycloplegia"
        },
        {
          "id": 290042,
          "text": "Skeletal muscle spasms"
        }
      ],
      "text": "Several children at a summer camp were hospitalized with symptoms thought to be due to ingestion of food containing botulinum toxin. The effects of botulinum toxin are likely to include",
      "unique_key": "Q7001077",
      "question_audio": null,
      "question_video": null,
      "map_id": 34998871,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Cycloplegia. Botulinum toxin is produced by Clostridium botulinum and causes botulism, a neuroparalytic disorder that results from the inhibition of acetylcholine (ACh) release at neuromuscular junctions and autonomic nerve terminals. This leads to flaccid paralysis and autonomic dysfunction. One of the key effects of botulinum toxin is cycloplegia (paralysis of the ciliary muscle of the eye), which results in loss of accommodation and blurred vision. This occurs because botulinum toxin blocks ACh release at muscarinic receptors in the eye, preventing contraction of the ciliary muscle necessary for near vision. Other ocular symptoms include ptosis (drooping eyelids) and diplopia (double vision). Explanation of Incorrect Options: A. Bronchospasm Botulinum toxin does not cause bronchospasm. Instead, it leads to respiratory muscle paralysis due to inhibition of ACh at the neuromuscular junction. While respiratory failure is a major cause of death in botulism, it is due to diaphragmatic and intercostal muscle paralysis, not bronchospasm (which involves excessive bronchoconstriction due to muscarinic overactivation, seen in conditions like asthma). B. Diarrhea Botulinum toxin affects cholinergic transmission, leading to constipation rather than diarrhea. Since ACh is important for peristalsis, its inhibition results in gastrointestinal stasis and severe constipation. This is in contrast to conditions like organophosphate poisoning, where excessive cholinergic activity leads to diarrhea. D. Skeletal Muscle Spasms Botulinum toxin causes flaccid paralysis, not muscle spasms. It inhibits the release of ACh at neuromuscular junctions, leading to progressive muscle weakness and paralysis, starting from the cranial nerves (causing ptosis, dysphagia, and diplopia) and progressing downward. This is the opposite of tetanus, which is caused by Clostridium tetani and results in spastic paralysis due to inhibition of inhibitory neurotransmitters (GABA and glycine).",
      "correct_choice_id": 290041,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31323941700120171/31323941700120171.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/31323941700120171/31323941700120171.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61208,
      "choices": [
        {
          "id": 290043,
          "text": "It is more potent"
        },
        {
          "id": 290044,
          "text": "It produces less muscarinic side effects"
        },
        {
          "id": 290045,
          "text": "It does not have any direct action on Nm receptors"
        },
        {
          "id": 290046,
          "text": "It is longer acting"
        }
      ],
      "text": "Which of the following properties make pyridostigmine different from neostigmine?",
      "unique_key": "Q6110558",
      "question_audio": null,
      "question_video": null,
      "map_id": 34692241,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) It is longer acting. Pyridostigmine and neostigmine are both indirect-acting cholinomimetics, specifically reversible acetylcholinesterase inhibitors used in the treatment of myasthenia gravis. The key difference is that pyridostigmine has a longer duration of action (4-6 hours) compared to neostigmine (2-4 hours). This makes pyridostigmine the preferred drug for chronic management of myasthenia gravis, while neostigmine is often used in acute settings, such as reversing neuromuscular blockade. The prolonged action of pyridostigmine results in less frequent dosing, improving patient compliance in long-term therapy. Explanation of Incorrect Options: A. It is more potent Pyridostigmine is not more potent than neostigmine; in fact, neostigmine is often considered to have a stronger acetylcholinesterase inhibitory effect. Pyridostigmine is preferred in chronic therapy because of its longer duration, not because of increased potency. B. It produces less muscarinic side effects Both pyridostigmine and neostigmine cause similar muscarinic side effects, such as increased salivation, sweating, diarrhea, and bradycardia. However, pyridostigmine’s slower onset and prolonged action might lead to a more gradual effect, but it does not inherently produce fewer muscarinic effects. Therefore, this option is incorrect. C. It does not have any direct action on Nm receptors Both neostigmine and pyridostigmine primarily act by inhibiting acetylcholinesterase, but neostigmine also has a direct agonistic effect on Nm (nicotinic muscular) receptors at the neuromuscular junction. Pyridostigmine has minimal to no direct Nm receptor action, but this is not the defining feature that sets it apart from neostigmine; rather, the key difference is its longer duration of action.",
      "correct_choice_id": 290046,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/14866541700120231/14866541700120231.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/14866541700120231/14866541700120231.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61209,
      "choices": [
        {
          "id": 290047,
          "text": "It has additional direct agonistic action on nicotinic receptors at the muscle end plate"
        },
        {
          "id": 290048,
          "text": "It is better absorbed orally"
        },
        {
          "id": 290049,
          "text": "It has longer duration of action"
        },
        {
          "id": 290050,
          "text": "It penetrates blood brain barrier"
        }
      ],
      "text": "Which of the following provides the best explanation for neostigmine being preferred over physostigmine for treating myasthenia gravis",
      "unique_key": "Q1766216",
      "question_audio": null,
      "question_video": null,
      "map_id": 34051061,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) It has additional direct agonistic action on nicotinic receptors at the muscle end plate. Neostigmine is a reversible acetylcholinesterase inhibitor that increases the availability of acetylcholine (ACh) at the neuromuscular junction (NMJ) by preventing its breakdown. Unlike physostigmine, neostigmine also has a direct stimulatory effect on nicotinic (Nm) receptors at the muscle end plate, enhancing neuromuscular transmission. This additional direct nicotinic agonistic action makes it more effective in treating myasthenia gravis, a condition characterized by autoimmune destruction of nicotinic receptors at the NMJ, leading to muscle weakness. The dual mechanism of acetylcholinesterase inhibition + direct nicotinic stimulation provides a stronger effect in improving muscle strength, which is why neostigmine is preferred over physostigmine. Explanation of Incorrect Options: B. It is better absorbed orally Physostigmine is actually better absorbed orally than neostigmine because it is lipid-soluble. Neostigmine is a quaternary amine, making it poorly lipid-soluble and less efficiently absorbed from the gastrointestinal tract. Despite its poor absorption, neostigmine is still preferred for myasthenia gravis due to its direct Nm receptor action. C. It has longer duration of action Neostigmine does not have a significantly longer duration of action than physostigmine. In fact, physostigmine's duration (2-4 hours) is comparable to that of neostigmine (2-4 hours). If a longer-acting drug were preferred, pyridostigmine (which lasts 4-6 hours) would be the better choice. Duration of action is not the key factor in neostigmine’s preference over physostigmine. D. It penetrates the blood-brain barrier Physostigmine is a tertiary amine, meaning it penetrates the blood-brain barrier (BBB) and has effects on the central nervous system (CNS), making it useful for reversing anticholinergic toxicity (e.g., atropine overdose). Neostigmine, being a quaternary amine, does not cross the BBB, which is actually beneficial for myasthenia gravis because it avoids unnecessary CNS effects. Since myasthenia gravis is a peripheral neuromuscular disorder, CNS penetration is not required.",
      "correct_choice_id": 290047,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73743591700120248/73743591700120248.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/73743591700120248/73743591700120248.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61210,
      "choices": [
        {
          "id": 290051,
          "text": "Cycloplegia"
        },
        {
          "id": 290052,
          "text": "Sweating"
        },
        {
          "id": 290053,
          "text": "Salivation"
        },
        {
          "id": 290054,
          "text": "Miosis"
        }
      ],
      "text": "A patient Raj Kishore was given pilocarpine. All of the following can be the features seen in him except",
      "unique_key": "Q2961150",
      "question_audio": null,
      "question_video": null,
      "map_id": 34887944,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Cycloplegia. Pilocarpine is a direct-acting cholinomimetic (muscarinic agonist) that primarily stimulates muscarinic receptors. When applied to the eye, pilocarpine induces miosis (pupil constriction) by stimulating the M3 receptors in the iris sphincter muscle. However, cycloplegia (paralysis of the ciliary muscle, leading to loss of accommodation) does not occur because pilocarpine stimulates rather than inhibits the ciliary muscle. Cycloplegia is typically caused by anticholinergic drugs (e.g., atropine, tropicamide), which block the muscarinic receptors and prevent ciliary muscle contraction. Since pilocarpine contracts the ciliary muscle, it actually improves near vision (accommodation) rather than causing cycloplegia. Explanation of Incorrect Options: B. Sweating Pilocarpine stimulates muscarinic receptors in sweat glands, leading to increased sweating (diaphoresis). This is an unusual effect because sweat glands are controlled by the sympathetic nervous system but use acetylcholine at muscarinic receptors. Excessive sweating is a well-known side effect of pilocarpine and is sometimes used therapeutically in conditions like Sjogren’s syndrome to promote salivation and sweating. C. Salivation Pilocarpine strongly stimulates M3 muscarinic receptors in salivary glands, leading to increased salivation. This effect is particularly useful in treating xerostomia (dry mouth), such as in Sjogren’s syndrome or post-radiation therapy for head and neck cancers. Increased salivation is one of the key cholinergic effects of pilocarpine. D. Miosis Pilocarpine causes miosis (pupil constriction) by stimulating M3 muscarinic receptors in the iris sphincter muscle. This leads to a smaller pupil size, which helps in the treatment of glaucoma by increasing aqueous humor outflow and lowering intraocular pressure (IOP).",
      "correct_choice_id": 290051,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45527321700120264/45527321700120264.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45527321700120264/45527321700120264.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61211,
      "choices": [
        {
          "id": 290055,
          "text": "Sweating"
        },
        {
          "id": 290056,
          "text": "Bradycardia"
        },
        {
          "id": 290057,
          "text": "Urination"
        },
        {
          "id": 290058,
          "text": "Rise in blood pressure"
        }
      ],
      "text": "All of the following effects are seen with cholinergic muscarinic receptor stimulation except",
      "unique_key": "Q3187149",
      "question_audio": null,
      "question_video": null,
      "map_id": 34640792,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Rise in blood pressure. Cholinergic muscarinic receptor stimulation primarily activates the parasympathetic nervous system, which generally causes a decrease in heart rate (bradycardia) and vasodilation, leading to a drop in blood pressure, not an increase. Muscarinic receptors are present in the heart (M2), smooth muscles, exocrine glands, and the eye (M3). Stimulation of M3 receptors in blood vessels causes vasodilation via nitric oxide (NO) release, leading to a decrease in blood pressure rather than an increase. This is why drugs that enhance cholinergic activity, such as acetylcholine or muscarinic agonists (e.g., pilocarpine, bethanechol), do not cause a rise in blood pressure. Explanation of Incorrect Options: A. Sweating Sweating is an exception to the usual parasympathetic effects because sweat glands are controlled by the sympathetic nervous system but use acetylcholine at muscarinic receptors. Stimulation of M3 muscarinic receptors in sweat glands leads to profuse sweating, which is a well-known effect of muscarinic agonists. B. Bradycardia Muscarinic receptor stimulation in the heart (M2 receptors) causes bradycardia (slowing of heart rate) by decreasing SA node activity and AV conduction. The parasympathetic nervous system reduces cardiac output, which further contributes to the drop in blood pressure. C. Urination Cholinergic stimulation promotes urination by activating M3 receptors in the detrusor muscle of the bladder, causing contraction. At the same time, muscarinic activation relaxes the internal urethral sphincter, facilitating urine outflow. This is why muscarinic agonists (e.g., bethanechol) are used to treat urinary retention.",
      "correct_choice_id": 290058,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58359701700120278/58359701700120278.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58359701700120278/58359701700120278.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61212,
      "choices": [
        {
          "id": 290059,
          "text": "Diagnosis of myasthenia gravis is done by gallantamine"
        },
        {
          "id": 290060,
          "text": "Botulinum toxin increases acetylcholine release"
        },
        {
          "id": 290061,
          "text": "Hemicholinium inhibits acetylcholine storage in vesicle"
        },
        {
          "id": 290062,
          "text": "Pralidoxime reactivates acetylcholinesterase"
        }
      ],
      "text": "Which of the following statement is/are true:",
      "unique_key": "Q7071385",
      "question_audio": null,
      "question_video": null,
      "map_id": 34243466,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Pralidoxime reactivates acetylcholinesterase. Pralidoxime (2-PAM) is a cholinesterase reactivator used in the treatment of organophosphate poisoning. Organophosphates irreversibly inhibit acetylcholinesterase (AChE) by phosphorylating its active site, leading to excessive accumulation of acetylcholine (ACh) at neuromuscular junctions and autonomic synapses. Pralidoxime works by removing the phosphate group from acetylcholinesterase, restoring its ability to break down ACh. However, pralidoxime is effective only before \"aging\" of the enzyme occurs, which is why it must be administered early in organophosphate poisoning. Explanation of Incorrect Options: A. Diagnosis of myasthenia gravis is done by gallantamine This statement is incorrect because gallantamine is not used for diagnosing myasthenia gravis. Instead, edrophonium, a short-acting acetylcholinesterase inhibitor, is used in the Tensilon test to diagnose myasthenia gravis. Edrophonium temporarily increases ACh at the neuromuscular junction, leading to improvement in muscle strength in myasthenic patients. Gallantamine, on the other hand, is used in the treatment of Alzheimer’s disease due to its cholinesterase inhibitory effects in the brain. B. Botulinum toxin increases acetylcholine release This statement is incorrect because botulinum toxin actually inhibits acetylcholine release, not increases it. Botulinum toxin, produced by Clostridium botulinum, cleaves SNARE proteins, which are essential for ACh vesicle fusion with the presynaptic membrane. This prevents the release of ACh at the neuromuscular junction, causing flaccid paralysis. This mechanism is why botulinum toxin is used in conditions like spasticity, dystonia, chronic migraines, and cosmetic wrinkle reduction. C. Hemicholinium inhibits acetylcholine storage in vesicles This statement is incorrect because hemicholinium inhibits choline uptake, not acetylcholine storage. Hemicholinium blocks the high-affinity choline transporter (CHT-1), preventing the reuptake of choline into the presynaptic neuron, which is essential for ACh synthesis. This leads to a decrease in ACh production over time, eventually depleting ACh stores. The drug that inhibits ACh storage in vesicles is vesamicol, which blocks the vesicular ACh transporter (VAChT).",
      "correct_choice_id": 290062,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41201361727532648/41201361727532648.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/41201361727532648/41201361727532648.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61213,
      "choices": [
        {
          "id": 290063,
          "text": "Tacrine not used in alzheimer’s disease because of hepatotoxicity risk"
        },
        {
          "id": 290064,
          "text": "Organophosphates binds to esteric site of acetylcholinesterase enzyme"
        },
        {
          "id": 290065,
          "text": "Atropine is a competitive antagonist of acetylcholine"
        },
        {
          "id": 290066,
          "text": "Acetylcholine not used because of long duration of action"
        }
      ],
      "text": "All are true regarding cholinergics except:",
      "unique_key": "Q5018037",
      "question_audio": null,
      "question_video": null,
      "map_id": 34476658,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Acetylcholine is not used because of its long duration of action. This statement is incorrect because acetylcholine (ACh) has an extremely short duration of action, not a long one. ACh is rapidly hydrolyzed by acetylcholinesterase (AChE) in the synaptic cleft, making its effects very brief. Due to this rapid breakdown, acetylcholine is not used as a therapeutic drug except in a few ophthalmic applications (e.g., intraocular surgery to induce miosis). Instead, cholinergic drugs with a longer half-life, such as bethanechol, pilocarpine, or neostigmine, are preferred for clinical use. Explanation of Incorrect Options: A. Tacrine is not used in Alzheimer’s disease because of hepatotoxicity risk This statement is correct. Tacrine was one of the first acetylcholinesterase inhibitors approved for Alzheimer’s disease treatment. However, it is rarely used today due to its significant hepatotoxicity risk, leading to elevated liver enzymes and potential liver damage. It has been largely replaced by newer cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, which have fewer hepatic side effects. B. Organophosphates bind to the esteric site of acetylcholinesterase enzyme This statement is correct. Organophosphates (such as malathion, parathion, and sarin gas) are irreversible inhibitors of acetylcholinesterase (AChE). They bind to the esteric (catalytic) site of AChE, phosphorylating the serine hydroxyl group, leading to enzyme inactivation and accumulation of ACh at cholinergic synapses. This causes cholinergic toxicity, characterized by salivation, lacrimation, urination, diarrhea, GI distress, miosis (SLUDGE), and neuromuscular paralysis. C. Atropine is a competitive antagonist of acetylcholine This statement is correct. Atropine is a muscarinic antagonist that competitively inhibits acetylcholine at muscarinic receptors (M1-M5). It is used to counteract cholinergic overstimulation, such as in organophosphate poisoning, bradycardia, and pre-anesthesia medication to reduce secretions. However, it does not block nicotinic receptors at the neuromuscular junction (NMJ), which is why pralidoxime (2-PAM) is needed alongside atropine in organophosphate poisoning to restore acetylcholinesterase function.",
      "correct_choice_id": 290066,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77370111727532691/77370111727532691.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/77370111727532691/77370111727532691.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61214,
      "choices": [
        {
          "id": 290067,
          "text": "Used in myasthenia gravis"
        },
        {
          "id": 290068,
          "text": "Quarternary ammonium compound"
        },
        {
          "id": 290069,
          "text": "Used with atropine in cobra bite"
        },
        {
          "id": 290070,
          "text": "Can cause urinary retention in post operative patients"
        }
      ],
      "text": "Regarding neostigmine all are true except:",
      "unique_key": "Q3187692",
      "question_audio": null,
      "question_video": null,
      "map_id": 34302062,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Can cause urinary retention in post-operative patients. This statement is incorrect because neostigmine actually relieves, rather than causes, urinary retention. Neostigmine is a reversible acetylcholinesterase inhibitor, which increases acetylcholine (ACh) levels at the neuromuscular junction and autonomic ganglia. By enhancing cholinergic transmission, it stimulates M3 muscarinic receptors in the bladder, leading to detrusor muscle contraction and relaxation of the internal sphincter, thereby promoting urination. Because of this effect, neostigmine is actually used to treat post-operative urinary retention rather than causing it. Explanation of Incorrect Options: A. Used in myasthenia gravis This statement is correct. Neostigmine is commonly used in the treatment of myasthenia gravis, a disorder characterized by autoimmune destruction of nicotinic receptors at the neuromuscular junction. By inhibiting acetylcholinesterase, neostigmine increases ACh levels, improving neuromuscular transmission and alleviating muscle weakness in affected patients. However, pyridostigmine is often preferred due to its longer duration of action. B. Quaternary ammonium compound This statement is correct. Neostigmine is a quaternary ammonium compound, meaning it carries a permanent positive charge. Because of this, it does not cross the blood-brain barrier (BBB), limiting its effects to peripheral cholinergic sites. This property differentiates it from physostigmine, which is a tertiary amine and can cross the BBB, making it useful in anticholinergic poisoning (e.g., atropine overdose). C. Used with atropine in cobra bite This statement is correct. Cobra venom contains neurotoxins that block nicotinic receptors at the neuromuscular junction, leading to paralysis and respiratory failure. Neostigmine is used to counteract this by increasing ACh levels, enhancing neuromuscular transmission. However, excessive cholinergic activity can lead to muscarinic side effects (such as bradycardia, excessive salivation, and bronchospasm), so atropine (a muscarinic antagonist) is administered alongside neostigmine to prevent these unwanted effects.",
      "correct_choice_id": 290070,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44784031727532717/44784031727532717.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44784031727532717/44784031727532717.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61215,
      "choices": [
        {
          "id": 290071,
          "text": "Cholinergic agents"
        },
        {
          "id": 290072,
          "text": "Anticholinergic agents"
        },
        {
          "id": 290073,
          "text": "Beta blockers"
        },
        {
          "id": 290074,
          "text": "Alpha agonists"
        }
      ],
      "text": "A patient receiving therapy with an acetylcholinesterase inhibitor presents with excessive salivation and diarrhea. What class of medication is likely causing these symptoms?",
      "unique_key": "Q1973372",
      "question_audio": null,
      "question_video": null,
      "map_id": 34833368,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Cholinergic agents. Acetylcholinesterase inhibitors increase acetylcholine (ACh) levels by preventing its breakdown at synaptic junctions, leading to enhanced cholinergic (muscarinic and nicotinic) effects. Excessive salivation (sialorrhea) and diarrhea are classic signs of muscarinic overstimulation, which results from excessive activation of M3 muscarinic receptors in the salivary glands and gastrointestinal tract. Other symptoms of cholinergic excess include lacrimation, urination, diarrhea, gastrointestinal cramping, emesis (SLUDGE) and bradycardia. Cholinergic toxicity can occur due to overdose or excessive response to acetylcholinesterase inhibitors, such as neostigmine, pyridostigmine, or organophosphates. Explanation of Incorrect Options: B. Anticholinergic agents This statement is incorrect because anticholinergic agents cause the opposite effects of those seen in the patient. Anticholinergic drugs (e.g., atropine, scopolamine, oxybutynin) block muscarinic receptors, leading to decreased salivation (dry mouth), constipation, urinary retention, and tachycardia. These agents are commonly used to reduce secretions, treat bradycardia, and manage motion sickness. C. Beta blockers This statement is incorrect because beta blockers primarily affect the cardiovascular system, rather than stimulating excessive salivation or diarrhea. Beta blockers (e.g., propranolol, atenolol, metoprolol) work by blocking beta-adrenergic receptors, reducing heart rate and blood pressure. While some non-selective beta blockers (e.g., propranolol) can cause mild gastrointestinal symptoms, they do not lead to excessive salivation or significant diarrhea as seen in cholinergic excess. D. Alpha agonists This statement is incorrect because alpha agonists (e.g., phenylephrine, clonidine) primarily affect vascular tone and blood pressure, rather than increasing secretions or causing diarrhea. Alpha-1 agonists (e.g., phenylephrine) cause vasoconstriction, increasing blood pressure, while alpha-2 agonists (e.g., clonidine, methyldopa) reduce sympathetic outflow, lowering blood pressure. These drugs do not stimulate muscarinic receptors, so they do not cause salivation or diarrhea.",
      "correct_choice_id": 290071,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64478041727532791/64478041727532791.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/64478041727532791/64478041727532791.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61216,
      "choices": [
        {
          "id": 290075,
          "text": "Neostigmine"
        },
        {
          "id": 290076,
          "text": "Pyridostigmine"
        },
        {
          "id": 290077,
          "text": "Atropine"
        },
        {
          "id": 290078,
          "text": "Edrophonium"
        }
      ],
      "text": "A patient with myasthenia gravis is treated with a medication to improve muscle strength. Which of the following medications is typically used?",
      "unique_key": "Q7556334",
      "question_audio": null,
      "question_video": null,
      "map_id": 34485036,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Pyridostigmine. Pyridostigmine is a reversible acetylcholinesterase inhibitor commonly used to treat myasthenia gravis, a condition characterized by autoimmune destruction of nicotinic receptors at the neuromuscular junction, leading to muscle weakness. Pyridostigmine increases acetylcholine (ACh) levels, thereby improving neuromuscular transmission and muscle strength. Pyridostigmine is preferred over other acetylcholinesterase inhibitors due to its longer duration of action and fewer side effects compared to neostigmine. Explanation of Incorrect Options: A. Neostigmine This statement is incorrect because while neostigmine is also used to treat myasthenia gravis, it is typically used in acute settings or hospitalized patients due to its shorter duration of action. Pyridostigmine is preferred for long-term management of myasthenia gravis because of its longer half-life and better patient compliance. Neostigmine, however, is used for more severe or emergency cases and may be used in combination with atropine to counteract side effects like bradycardia. C. Atropine This statement is incorrect because atropine is an anticholinergic drug, not an acetylcholinesterase inhibitor. Atropine is used to treat bradycardia and reduce secretions in various conditions, but it does not improve muscle strength in myasthenia gravis. In fact, atropine could worsen myasthenia gravis symptoms by inhibiting muscarinic effects on smooth muscles and exocrine glands, such as causing dry mouth and difficulty swallowing. D. Edrophonium This statement is incorrect because edrophonium is used primarily for diagnosis of myasthenia gravis in the Tensilon test, rather than for long-term treatment. Edrophonium is a short-acting acetylcholinesterase inhibitor that briefly increases ACh levels, improving muscle strength in myasthenia gravis patients for a short duration. It is useful in confirming the diagnosis but is not typically used for chronic management of the condition.",
      "correct_choice_id": 290076,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62084031727532839/62084031727532839.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62084031727532839/62084031727532839.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61217,
      "choices": [
        {
          "id": 290079,
          "text": "Succinylcholine"
        },
        {
          "id": 290080,
          "text": "Neostigmine"
        },
        {
          "id": 290081,
          "text": "Atropine"
        },
        {
          "id": 290082,
          "text": "Pyridostigmine"
        }
      ],
      "text": "Which of the following medications can be used to reverse the effects of a non-depolarizing neuromuscular blocker?",
      "unique_key": "Q7107858",
      "question_audio": null,
      "question_video": null,
      "map_id": 34016378,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Neostigmine. Neostigmine is a reversible acetylcholinesterase inhibitor that is used to reverse the effects of non-depolarizing neuromuscular blockers (e.g., rocuronium, vecuronium, atracurium). Non-depolarizing neuromuscular blockers work by competing with acetylcholine (ACh) for binding to nicotinic receptors at the neuromuscular junction, preventing muscle contraction. Neostigmine inhibits acetylcholinesterase, the enzyme responsible for breaking down ACh, thereby increasing the amount of ACh available to outcompete the neuromuscular blocker and reverse paralysis. Neostigmine is often given with atropine to counteract its muscarinic side effects (e.g., bradycardia). Explanation of Incorrect Options: A. Succinylcholine This statement is incorrect because succinylcholine is a depolarizing neuromuscular blocker, not a non-depolarizing one. It works by persistently depolarizing the neuromuscular junction, causing an initial muscle contraction followed by paralysis. Succinylcholine cannot reverse the effects of non-depolarizing blockers, and in fact, it has its own risks, including malignant hyperthermia and prolonged paralysis. C. Atropine This statement is incorrect because atropine is a muscarinic antagonist, not an acetylcholinesterase inhibitor. It is used to treat bradycardia or to counteract muscarinic side effects (like excessive salivation) that can result from neostigmine administration. Atropine does not reverse the effects of non-depolarizing neuromuscular blockers, as it does not address the mechanism of action of these drugs. D. Pyridostigmine This statement is incorrect because pyridostigmine is an acetylcholinesterase inhibitor similar to neostigmine, but it is not typically used for reversing neuromuscular blockers in acute settings. Pyridostigmine is often used for chronic management of myasthenia gravis, where longer-term enhancement of cholinergic activity is needed. Neostigmine is preferred in the acute reversal of neuromuscular blockade because it has a more rapid onset of action and is more effective in this specific context.",
      "correct_choice_id": 290080,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17218941727533203/17218941727533203.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/17218941727533203/17218941727533203.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61218,
      "choices": [
        {
          "id": 290083,
          "text": "Varenicline"
        },
        {
          "id": 290084,
          "text": "Bupropion"
        },
        {
          "id": 290085,
          "text": "Nicotine gum"
        },
        {
          "id": 290086,
          "text": "Nortriptyline"
        }
      ],
      "text": "A 50-year-old man with a 30-pack-year smoking history is motivated to quit smoking. He expresses interest in using pharmacotherapy to aid his cessation efforts. Which of the following medications is a nicotine receptor partial agonist and can help reduce withdrawal symptoms and cravings?",
      "unique_key": "Q7788607",
      "question_audio": null,
      "question_video": null,
      "map_id": 34210893,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Varenicline. Varenicline is a nicotine receptor partial agonist that is commonly used as a first-line pharmacotherapy for smoking cessation. It works by binding to nicotinic acetylcholine receptors, partially stimulating them to release dopamine and thus reducing withdrawal symptoms and cravings associated with smoking cessation. At the same time, it blocks nicotine from binding to these receptors, which helps to reduce the reinforcing effects of smoking. Varenicline is effective in helping individuals quit smoking and has been shown to improve cessation rates when used in combination with behavioral support. Explanation of Incorrect Options: B. Bupropion This statement is incorrect, although bupropion is indeed used as a pharmacotherapy for smoking cessation. Bupropion is an atypical antidepressant that works by inhibiting the reuptake of norepinephrine and dopamine. It helps reduce withdrawal symptoms and cravings, but it does not act directly on nicotine receptors. Instead, its action on dopamine pathways is thought to contribute to its ability to aid smoking cessation. However, varenicline is a more specific and targeted treatment for nicotine dependence, as it directly affects the nicotine receptor. C. Nicotine gum This statement is incorrect because nicotine gum is a nicotine replacement therapy (NRT), not a nicotine receptor partial agonist. Nicotine gum provides a low dose of nicotine to help manage withdrawal symptoms and cravings by directly replacing the nicotine that the body craves. However, unlike varenicline, nicotine gum does not alter the nicotine receptor activity in the same way. While nicotine gum is effective in helping people quit smoking, varenicline has the advantage of addressing both cravings and withdrawal symptoms through its partial agonist action on nicotine receptors. D. Nortriptyline This statement is incorrect because nortriptyline is a tricyclic antidepressant that can be used off-label to help with smoking cessation, but it is not a nicotine receptor partial agonist. Nortriptyline works by increasing norepinephrine and serotonin levels in the brain, which can help with mood regulation and withdrawal symptoms. However, its action is not as directly targeted to nicotine receptors, and it is generally considered less effective and has more side effects compared to varenicline or bupropion.",
      "correct_choice_id": 290083,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61219,
      "choices": [
        {
          "id": 290087,
          "text": "It provides nicotine replacement."
        },
        {
          "id": 290088,
          "text": "It reduces cravings and withdrawal symptoms."
        },
        {
          "id": 290089,
          "text": "It is only effective when combined with nicotine patches."
        },
        {
          "id": 290090,
          "text": "It has a high risk of addiction."
        }
      ],
      "text": "A 45-year-old woman is attempting to quit smoking and is prescribed bupropion. Which of the following is a key benefit of this medication in the context of smoking cessation?",
      "unique_key": "Q6536244",
      "question_audio": null,
      "question_video": null,
      "map_id": 34365616,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) It reduces cravings and withdrawal symptoms. Bupropion is an atypical antidepressant that is commonly used to aid in smoking cessation. It works by inhibiting the reuptake of norepinephrine and dopamine, which helps to reduce cravings and withdrawal symptoms associated with quitting smoking. Additionally, bupropion has the added benefit of improving mood and decreasing the likelihood of relapse due to its effects on dopamine. It is not a nicotine replacement therapy (NRT) but still provides significant support during smoking cessation by addressing both cravings and mood disturbances. Explanation of Incorrect Options: A. It provides nicotine replacement This statement is incorrect because bupropion does not provide nicotine replacement. Nicotine replacement therapies (NRT), such as nicotine patches, gum, or lozenges, directly provide nicotine to reduce cravings and withdrawal symptoms. Bupropion, on the other hand, works by modulating neurotransmitters in the brain to help manage cravings and withdrawal, but it does not provide nicotine itself. C. It is only effective when combined with nicotine patches This statement is incorrect because bupropion can be effective on its own for smoking cessation. While it is sometimes used in combination with nicotine replacement therapies like nicotine patches, it is not dependent on their use. Bupropion is a standalone treatment that can reduce cravings and withdrawal symptoms effectively without the need for nicotine patches or other nicotine-containing products. D. It has a high risk of addiction This statement is incorrect because bupropion has a low risk of addiction. Unlike nicotine or other addictive substances, bupropion does not cause the same dependence. In fact, bupropion is used to help individuals quit smoking and has no significant abuse potential when taken as prescribed. While there are some risks associated with its use, such as seizures, these are relatively rare and occur at higher doses or in certain at-risk individuals.",
      "correct_choice_id": 290088,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 61220,
      "choices": [
        {
          "id": 290091,
          "text": "Varenicline"
        },
        {
          "id": 290092,
          "text": "Nicotine replacement therapy"
        },
        {
          "id": 290093,
          "text": "Bupropion"
        },
        {
          "id": 290094,
          "text": "Nortriptyline"
        }
      ],
      "text": "A 37-year-old man has been smoking for 15 years and is ready to quit. He is concerned about weight gain during cessation. Which of the following medications can help mitigate this concern while aiding in smoking cessation?",
      "unique_key": "Q4402611",
      "question_audio": null,
      "question_video": null,
      "map_id": 34449521,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Bupropion. Bupropion is an atypical antidepressant that is commonly used for smoking cessation. One of the key benefits of bupropion is that it can help reduce the likelihood of weight gain during smoking cessation, which is a common concern among people quitting smoking. Bupropion works by modulating dopamine and norepinephrine in the brain, which helps control appetite and reduce cravings. Unlike many other smoking cessation therapies, bupropion does not generally lead to weight gain and may even promote weight loss in some individuals. This makes it an ideal choice for people concerned about gaining weight during the quitting process. Explanation of Incorrect Options: A. Varenicline This statement is incorrect because varenicline is a nicotine receptor partial agonist that aids in smoking cessation by reducing cravings and withdrawal symptoms. While varenicline is effective for quitting smoking, it does not specifically help with the concern of weight gain. Some studies suggest that varenicline may be associated with modest weight gain due to its effects on appetite and eating behaviors, but it is not the best option for weight management during smoking cessation. B. Nicotine replacement therapy This statement is incorrect because while nicotine replacement therapies (NRTs), such as nicotine gum, patches, or lozenges, help to reduce cravings and withdrawal symptoms, they do not directly address the concern of weight gain. NRTs provide nicotine to help prevent withdrawal, but they do not alter the effects of nicotine on appetite and metabolism. In fact, some individuals may still experience weight gain when using NRTs, as nicotine can act as an appetite suppressant, and quitting smoking may lead to an increase in food intake. D. Nortriptyline This statement is incorrect because nortriptyline is a tricyclic antidepressant that is sometimes used off-label for smoking cessation, particularly in individuals who are unable to use other medications. However, nortriptyline does not specifically mitigate weight gain during smoking cessation. In fact, nortriptyline may be associated with weight gain as a side effect due to its effects on serotonin and norepinephrine. It is not the best choice for someone specifically concerned about weight gain during smoking cessation.",
      "correct_choice_id": 290093,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}